What is Ayogo?
Founded in 2008, Ayogo has developed the Glimpse Platform, a proprietary system designed to enhance patient activation, adherence, and persistence to therapy. The platform achieves this by tailoring content, tools, and support to the unique psychosocial characteristics of each individual. This personalized approach aims to bridge the gap between treatment plans and patient engagement, a critical factor in achieving successful health outcomes. Ayogo operates within the rapidly evolving digital health sector, where personalized medicine and patient-centric solutions are increasingly paramount.
How much funding has Ayogo raised?
Ayogo has raised a total of $10M across 2 funding rounds:
Series A
$2.5M
Series B
$7.5M
Series A (2015): $2.5M with participation from Excel Venture Management, 7Wire Ventures, and Merck Global Health Innovations
Series B (2020): $7.5M led by Merck Global Health Innovation Fund, 7Wire Ventures, Baxter International Inc, Excel Venture Management, and MEDTEQ
Key Investors in Ayogo
Excel Venture Management
Excel Venture Management is an investment firm that typically backs companies in the healthcare and life sciences sectors, focusing on innovative technologies that can disrupt traditional markets.
7Wire Ventures
7Wire Ventures is a venture capital firm that invests in transformative digital health companies, aiming to improve healthcare outcomes and reduce costs through technology.
Merck Global Health Innovations
Merck Global Health Innovations, part of the global healthcare company Merck & Co., Inc., invests in early-stage companies developing innovative solutions for healthcare challenges, particularly in areas of unmet medical need.
What's next for Ayogo?
The recent major strategic investment signals a new phase of expansion and development for Ayogo. This capital infusion is likely to fuel further innovation in the Glimpse Platform, potentially broadening its therapeutic applications and market reach. Ayogo may also focus on scaling its operations, forging new partnerships within the healthcare ecosystem, and enhancing its data analytics capabilities to further refine its personalized patient engagement strategies. The company's continued access to substantial funding suggests a strong outlook for its role in shaping the future of patient care through technology.
See full Ayogo company page
